Baojie Wan - Concepedia

Author

Baojie Wan

University of Illinois Chicago

Also Known As

Baojie Wan, Kawaljit Singh, Wan Baojie, Wan, Baojie

105

Publications

Citations

H-Index

Concepts

All Affiliations

University of Illinois Chicago TB Alliance University of Auckland Cancer Society of New Zealand University of Antwerp

About

Baojie Wan is an author at University of Illinois Chicago specializing in pharmacology, medicine, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	24	34	1.5K
2	Biochemistry	16	20	894
3	Natural Sciences	14	17	826
4	Engineering	3	3	95
5	Health Sciences	2	2	83

Baojie Wan

Publications

3.6K

Citations

H-Index

Page 1

	Year	Citations
Structure−Activity Relationships for a Series of Quinoline-Based Compounds Active against Replicating and Nonreplicating<i>Mycobacterium tuberculosis</i> Annamaria Lilienkampf, Jialin Mao, Baojie Wan, Journal of Medicinal Chemistry	2009	301
Low-Oxygen-Recovery Assay for High-Throughput Screening of Compounds against Nonreplicating <i>Mycobacterium tuberculosis</i> Sang‐Hyun Cho, Saradee Warit, Baojie Wan, Antimicrobial Agents and Chemotherapy	2007	292
Synthesis, antimalarial and antitubercular activity of acetylenic chalcones Renate Hans, Eric M. Guantai, Carmen Lategan, Bioorganic & Medicinal Chemistry Letters PharmacologyAcetylenic ChalconesNatural Product Synthesis	2009	157
Synthesis and evaluation of anti-tubercular and antibacterial activities of new 4-(2,6-dichlorobenzyloxy)phenyl thiazole, oxazole and imidazole derivatives. Part 2 Xiaoyun Lu, Xiaobo Liu, Baojie Wan, European Journal of Medicinal Chemistry Imidazole DerivativesMedicinal ChemistryAntibacterial AgentAntimicrobial ChemotherapyPhenyl Thiazole	2012	128
Discovery of Novel Oral Protein Synthesis Inhibitors of Mycobacterium tuberculosis That Target Leucyl-tRNA Synthetase Andrés Palencia, Xianfeng Li, Wei Bu, Antimicrobial Agents and Chemotherapy Drug TargetMolecular BiologyAntimicrobial ChemotherapyProtein SynthesisDrug Resistance	2016	116
Synthesis and Structure–Activity Relationships of Varied Ether Linker Analogues of the Antitubercular Drug (6<i>S</i>)-2-Nitro-6-{[4-(trifluoromethoxy)benzyl]oxy}-6,7-dihydro-5<i>H</i>-imidazo[2,1-<i>b</i>][1,3]oxazine (PA-824) Andrew M. Thompson, Hamish S. Sutherland, Brian D. Palmer, Journal of Medicinal Chemistry Pharmaceutical ScienceOrganic ChemistryAntimicrobial ChemotherapyChemistryHeterocycle Chemistry	2011	109
Synthesis and Structure−Activity Studies of Biphenyl Analogues of the Tuberculosis Drug (6<i>S</i>)-2-Nitro-6-{[4-(trifluoromethoxy)benzyl]oxy}-6,7-dihydro-5<i>H</i>-imidazo[2,1-<i>b</i>][1,3]oxazine (PA-824) Brian D. Palmer, Andrew M. Thompson, Hamish S. Sutherland, Journal of Medicinal Chemistry	2009	109
From Serendipity to Rational Antituberculosis Drug Discovery of Mefloquine-Isoxazole Carboxylic Acid Esters Jialin Mao, Hai Yuan, Yuehong Wang, Journal of Medicinal Chemistry	2009	106
Design, Synthesis, and SAR Studies of Mefloquine‐Based Ligands as Potential Antituberculosis Agents Sarva Jayaprakash, Yasuyoshi Iso, Baojie Wan, ChemMedChem Bioorganic ChemistryTuberculosis PreventionAntimicrobial ChemotherapyChemistryPharmaceutical Chemistry	2006	105
Design, Synthesis, and Biological Evaluation of Pyrazolo[1,5-<i>a</i>]pyridine-3-carboxamides as Novel Antitubercular Agents Jian Tang, Bangxing Wang, Tian Shung Wu, ACS Medicinal Chemistry Letters Pulmonary TuberculosisBiochemistryMedicineTuberculosis PreventionNovel Antitubercular Agents	2015	95

Page 1